LifeVantage Corp is a company operating in the health and wellness industry. Its business model focuses on the development, manufacturing, and distribution of scientifically advanced nutritional supplements. LifeVantage Corp primarily offers products that aim to improve overall health and well-being, with a particular emphasis on cellular health. By leveraging scientific research and cutting-edge technologies, LifeVantage Corp strives to provide innovative solutions to individuals seeking to enhance their quality of life. Through its network marketing approach, the company also empowers independent distributors to share these products and earn income while promoting a healthier lifestyle.

LifeVantage Corp is primarily active in the health and wellness industry.

The main competitors of LifeVantage Corp in the market are Amway, Herbalife, Nu Skin Enterprises, and Usana Health Sciences.

LifeVantage Corp is a renowned health and wellness company established in 2003. Headquartered in Sandy, Utah, LifeVantage is dedicated to developing science-backed nutrigenomics products, aiming to redefine wellness and promote healthy living. With a mission to help individuals achieve their health goals, LifeVantage is committed to providing innovative nutritional supplements and skincare solutions that support overall well-being. As a leader in the direct-selling industry, LifeVantage has a global presence in North America, Europe, and the Asia-Pacific region. With its cutting-edge product line and focus on personalized health, LifeVantage Corp has become a trusted name in the wellness industry.

LifeVantage Corp has achieved several significant milestones in its journey. Firstly, the company successfully launched Protandim®, its flagship product, in 2005. This revolutionary dietary supplement gained immense popularity for its unique antioxidant properties. In 2008, LifeVantage Corp received widespread recognition when it was listed on the NASDAQ Stock Exchange. The company continued to expand its product portfolio and in 2016, introduced Axio®, a range of energy drinks. LifeVantage Corp's commitment to innovation and scientific research led to the development of NRF2 Synergizer™, a breakthrough formula in 2019. These achievements demonstrate LifeVantage Corp's continuous growth and dedication to providing high-quality wellness products to its consumers worldwide.

LifeVantage Corp primarily operates in countries and regions across the globe. The company has a significant presence in the United States, where it is headquartered. Additionally, LifeVantage Corp has established a strong foothold in Canada, Mexico, Japan, Australia, Hong Kong, and the Netherlands. With a wide-ranging international network, LifeVantage Corp continues to expand its footprint and reach customers in various markets.

LifeVantage Corp represents values and a corporate philosophy that emphasizes science-based solutions for better health and wellness. The company is committed to providing innovative products backed by extensive research and clinical studies. LifeVantage Corp is dedicated to empowering people to live healthier and happier lives through its leading-edge nutrigenomics technology. The company focuses on developing and distributing products that target oxidative stress, promote healthy aging, and support overall well-being. LifeVantage Corp's commitment to quality, integrity, and innovation drives its mission to help individuals achieve their health and financial goals. By combining cutting-edge science and a passion for transformative results, LifeVantage Corp is revolutionizing the way people approach their health and wellness.

Analysts currently set an average price target of 14,79 USD for the LifeVantage stock (median: 14,79 USD), implying +135,1 % versus the latest price. The consensus is based on 8 analyst ratings.

LifeVantage Analyytikkojen kursstavoitteet 2026

8 analysts currently rate the LifeVantage stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect LifeVantage to generate revenue of 184,20 M USD and earnings per share of 0,58 USD.

LifeVantage Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the LifeVantage share trades at 5,50 EUR (6,33 USD).

The LifeVantage share (LFVN) is listed on 2 stock exchanges, including: NASDAQ (LFVN), Frankfurt (L2T1.F).

The LifeVantage Corporation is a company that operates in the health and wellness market. It is considered a leading provider of nutritional supplements and skincare products. The company's business models are centered around direct selling and multi-level marketing (MLM), which means that independent distributors sell the products directly to end customers. The main products of LifeVantage are the nutritional supplements Protandim, Axio, and PhysIQ, as well as the skincare series TrueScience. All of these products are designed to improve the health and well-being of the user. Protandim is a nutritional supplement that has antioxidant and anti-inflammatory properties to support the immune system and cellular health. Axio is a drink-like nutritional supplement specifically designed to enhance mental clarity and energy. PhysIQ contains products that focus on healthy weight loss, metabolism, and digestive issues, while TrueScience skincare products provide antioxidant protection, anti-aging properties, and moisture to reduce damage from environmental factors or aging. According to the company, all products undergo comprehensive clinical studies to ensure effectiveness and safety, in order to provide customers with essential quality standards. The production of LifeVantage products takes place in excellent manufacturing facilities, and all ingredients are carefully reviewed. LifeVantage products are sold directly to independent distributors, who then sell these products to end customers. The multi-level marketing model of LifeVantage is aimed at supporting independent distributors. These distributors are able to build their own sales by selling products to customers and recruiting new distributors. Through this process, they can also earn commissions and increase their income by selling LifeVantage products and acquiring customers in their team. The LifeVantage Corporation also has a presence on social media platforms such as Facebook, Twitter, Instagram, and LinkedIn. Here, customers and prospects can be informed about current products and offers and establish connections with others in the LifeVantage community. They can also share their own experiences and make recommendations. Overall, the business model of LifeVantage is focused on direct sales and multi-level marketing. It provides independent distributors with the opportunity to build their own sales by selling products to customers and recruiting new distributors. Through this model, distributors can earn commissions and increase their income. LifeVantage products are tested for effectiveness and safety through clinical studies and are sold directly to distributors, who then resell them to end customers. The company's presence on social media and its focus on health and wellness-oriented products ensure that LifeVantage continues to be on a growth trajectory.

odotettu liikevaihto LifeVantage on 184,20 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto LifeVantage on 7,45 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

LifeVantage:n hinta-voitto-suhde (P/E) on tällä hetkellä 10,84. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan LifeVantage-osakkeen arvostusta.

LifeVantage:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,44. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii LifeVantage-osakkeen arvostuskennuslukuna.

LifeVantage:n Eulpool-laatuscore on 3/10.

LifeVantage:n ISIN on US53222K2050. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

LifeVantage:n WKN on A1420J. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

LifeVantage:n ticker on LFVN. Tämä pörssinoteeraus käytetään LifeVantage-osakkeiden kauppaan pörssissä.

Viimeisten 12 kuukauden aikana LifeVantage maksoi osinkoa 0,18 USD . Tämä vastaa osingontuottoa noin 2,76 %. Tulevien 12 kuukauden aikana LifeVantage odotetaan maksavan osinkoa 0,21 USD.

LifeVantage:n nykyinen osinkotuotto on 2,76 %.

LifeVantage maksaa osinkoa, joka jaetaan kuukausina , , , .

LifeVantage maksoi osinkoa joka vuosi viimeisten 4 vuoden aikana.

Tulevien 12 kuukauden aikana odotetaan osinkoja, joiden määrä on 0,21 USD. Tämä vastaa osingontuottoa 3,33 %.

LifeVantage kuuluu sektoriin 'Ei-syklinen kulutus'.

Saadaksesi viimeisen osingon LifeVantage:sta päivältä määrässä 0,05 USD, sinulla piti olla osake portfoliossasi ennen irtoamispäivää .

Viimeinen osinko maksettiin .

Vuonna 2025 LifeVantage jakoi 0,15 USD osinkona.

LifeVantage:n osingot jaetaan valuutassa USD.